ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

General Practice

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

19,126Medicare Part D Prescriptions Filled, Including Refills

Rank: 18 out of 517

$893K Total Retail Price of All Prescriptions

Rank: 26 out of 517

620 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
89% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

20% of this provider’s 620 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

5% of this provider’s 17,180 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
OMEPRAZOLE 1,148 1,037 1 3
ALENDRONATE SODIUM 1,051 992 2 11
SIMVASTATIN 790 699 3 1
TRAMADOL HCL 789 726 4 19
AMLODIPINE BESYLATE 643 601 5 2
DIOVAN HCT 615 571 6 31
GLYBURIDE-METFORMIN HCL 589 484 R 7 57
MELOXICAM 516 473 8 25
METFORMIN HCL 452 408 9 4
GABAPENTIN 450 385 10 13
LOSARTAN-HYDROCHLOROTHIAZIDE 442 416 11 50
ZOLPIDEM TARTRATE 435 408 12 14
HYDROCHLOROTHIAZIDE 398 364 13 10
LEVOTHYROXINE SODIUM 386 364 14 6
BENAZEPRIL HCL 381 360 15 15
CARVEDILOL 339 325 16 26
FLUOCINONIDE 327 272 17 86
METOPROLOL TARTRATE 312 291 18 18
IBUPROFEN 284 215 19 16
FUROSEMIDE 258 219 20 9
METOPROLOL SUCCINATE 208 191 21 21
BUSPIRONE HCL 198 163 22 121
AZITHROMYCIN 198 165 22 41
KLOR-CON 8 195 183 24 98
TAMSULOSIN HCL 184 180 25 22
ISOSORBIDE MONONITRATE ER 183 175 26 70
GLIMEPIRIDE 182 177 27 35
HYDROCODONE-ACETAMINOPHEN 171 138 S3 28 5
BENICAR HCT 157 148 29 166
JANUVIA 144 139 30 43
LISINOPRIL 138 135 31 7
PAROXETINE HCL 137 135 32 76
ACTOS 137 112 32 51
DIOVAN 134 128 34 20
NEXIUM 128 111 35 29
BENAZEPRIL-HYDROCHLOROTHIAZIDE 125 120 36 153
BENICAR 123 109 37 105
CLONIDINE HCL 118 97 38 59
ACETAMINOPHEN-CODEINE 112 90 S3 39 48
CELEBREX 109 100 40 40
VALSARTAN-HYDROCHLOROTHIAZIDE 106 98 41 226
ONGLYZA 105 104 42 172
CILOSTAZOL 103 103 43 136
PROAIR HFA 96 60 44 33
GLYCOPYRROLATE 93 92 45 301
ZOSTAVAX 89 79 46 329
GLYBURIDE 89 80 R 46 53
ATORVASTATIN CALCIUM 87 77 48 12
LEVEMIR 83 67 49 260
AMOXICILLIN 83 64 49 58
ATENOLOL 82 70 51 8
ALLOPURINOL 81 54 52 37
FLUTICASONE PROPIONATE 80 70 53 45
SINGULAIR 73 51 54 64
ASPIR-LOW 73 73 54 306
ADVAIR DISKUS 73 55 54 46
PATADAY 72 65 57 138
PREDNISONE 70 60 58 89
AMITRIPTYLINE HCL 70 70 R 58 96
DONEPEZIL HCL 69 69 60 28
MEGACE ES 66 66 R 61 394
TRILIPIX 64 63 62 194
ECONAZOLE NITRATE 63 55 63 145
POTASSIUM CHLORIDE 60 54 64 34
CLOPIDOGREL 56 48 65 47
DICLOFENAC SODIUM 55 51 66 56
CRESTOR 52 43 67 27
RISACAL-D 50 50 10 68 432
PLAVIX 50 41 68 62
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.